Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA03010060 11b PGE2 cPLA2i 1.0 BCD110605C28 0.01 pmol/ml medium
LMFA03010060 11b PGE2 cPLA2i 1.0 BCD110605C30 0.017 pmol/ml medium
LMFA03010060 11b PGE2 cPLA2i 1.0 BCD110605C29 0.014 pmol/ml medium
LMFA03010060 11b PGE2 cPLA2i 20.0 BCD110605C64 0.014 pmol/ml medium
LMFA03010060 11b PGE2 cPLA2i 20.0 BCD110605C66 0.014 pmol/ml medium
LMFA03010060 11b PGE2 cPLA2i 20.0 BCD110605C65 0.015 pmol/ml medium
LMFA03010060 11b PGE2 PLDi 1.0 BCD110605C16 0.026 pmol/ml medium
LMFA03010060 11b PGE2 PLDi 1.0 BCD110605C17 0.017 pmol/ml medium
LMFA03010060 11b PGE2 PLDi 1.0 BCD110605C18 0.02 pmol/ml medium
LMFA03010060 11b PGE2 PLDi 20.0 BCD110605C54 0.018 pmol/ml medium
LMFA03010060 11b PGE2 PLDi 20.0 BCD110605C52 0.029 pmol/ml medium
LMFA03010060 11b PGE2 PLDi 20.0 BCD110605C53 0.024 pmol/ml medium
LMFA03010060 11b PGE2 KDO+cPLA2i 1.0 BCD110605C32 0.015 pmol/ml medium
LMFA03010060 11b PGE2 KDO+cPLA2i 1.0 BCD110605C31 0.016 pmol/ml medium
LMFA03010060 11b PGE2 KDO+cPLA2i 1.0 BCD110605C33 0.023 pmol/ml medium
LMFA03010060 11b PGE2 KDO+cPLA2i 20.0 BCD110605C68 0.029 pmol/ml medium
LMFA03010060 11b PGE2 KDO+cPLA2i 20.0 BCD110605C69 0.035 pmol/ml medium
LMFA03010060 11b PGE2 KDO+cPLA2i 20.0 BCD110605C67 0.021 pmol/ml medium
LMFA03010060 11b PGE2 KDO+PLDi 1.0 BCD110605C19 0.013 pmol/ml medium
LMFA03010060 11b PGE2 KDO+PLDi 1.0 BCD110605C20 0.012 pmol/ml medium
LMFA03010060 11b PGE2 KDO+PLDi 1.0 BCD110605C21 0.022 pmol/ml medium
LMFA03010060 11b PGE2 KDO+PLDi 20.0 BCD110605C56 0.039 pmol/ml medium
LMFA03010060 11b PGE2 KDO+PLDi 20.0 BCD110605C57 0.044 pmol/ml medium
LMFA03010060 11b PGE2 KDO+PLDi 20.0 BCD110605C55 0.027 pmol/ml medium
LMFA03010060 11b PGE2 KDO+ATP+cPLA2i 1.0 BCD110605C37 0.037 pmol/ml medium
LMFA03010060 11b PGE2 KDO+ATP+cPLA2i 1.0 BCD110605C38 0.051 pmol/ml medium
LMFA03010060 11b PGE2 KDO+ATP+cPLA2i 1.0 BCD110605C39 0.036 pmol/ml medium
LMFA03010060 11b PGE2 KDO+ATP+cPLA2i 20.0 BCD110605C74 0.067 pmol/ml medium
LMFA03010060 11b PGE2 KDO+ATP+cPLA2i 20.0 BCD110605C75 0.073 pmol/ml medium
LMFA03010060 11b PGE2 KDO+ATP+cPLA2i 20.0 BCD110605C73 0.076 pmol/ml medium
LMFA03010060 11b PGE2 KDO+ATP+PLDi 1.0 BCD110605C25 0.028 pmol/ml medium
LMFA03010060 11b PGE2 KDO+ATP+PLDi 1.0 BCD110605C27 0.039 pmol/ml medium
LMFA03010060 11b PGE2 KDO+ATP+PLDi 1.0 BCD110605C26 0.031 pmol/ml medium
LMFA03010060 11b PGE2 KDO+ATP+PLDi 20.0 BCD110605C61 0.156 pmol/ml medium
LMFA03010060 11b PGE2 KDO+ATP+PLDi 20.0 BCD110605C62 0.142 pmol/ml medium
LMFA03010060 11b PGE2 KDO+ATP+PLDi 20.0 BCD110605C63 0.166 pmol/ml medium
LMFA03010060 11b PGE2 KDO + ATP 1.0 BCD110605C15 0.028 pmol/ml medium
LMFA03010060 11b PGE2 KDO + ATP 1.0 BCD110605C14 0.038 pmol/ml medium
LMFA03010060 11b PGE2 KDO + ATP 1.0 BCD110605C13 0.033 pmol/ml medium
LMFA03010060 11b PGE2 KDO + ATP 20.0 BCD110605C49 0.198 pmol/ml medium
LMFA03010060 11b PGE2 KDO + ATP 20.0 BCD110605C50 0.157 pmol/ml medium
LMFA03010060 11b PGE2 KDO + ATP 20.0 BCD110605C51 0.158 pmol/ml medium
LMFA03010060 11b PGE2 KDO 1.0 BCD110605C08 0.032 pmol/ml medium
LMFA03010060 11b PGE2 KDO 1.0 BCD110605C07 0.064 pmol/ml medium
LMFA03010060 11b PGE2 KDO 1.0 BCD110605C09 0.036 pmol/ml medium
LMFA03010060 11b PGE2 KDO 20.0 BCD110605C45 0.035 pmol/ml medium
LMFA03010060 11b PGE2 KDO 20.0 BCD110605C44 0.04 pmol/ml medium
LMFA03010060 11b PGE2 KDO 20.0 BCD110605C43 0.033 pmol/ml medium
LMFA03010060 11b PGE2 C 0.0 BCD110605C03 0.038 pmol/ml medium
LMFA03010060 11b PGE2 C 0.0 BCD110605C01 0.07 pmol/ml medium